Complete Vision Capability

Demonstrated components (today): The eye already carries its own neuroprotective and antioxidant defenses, and AI retinal screening can read those tissues to flag disease before it costs sight. Catching deviation early and reinforcing the eye’s own protective biology are clinically real today — preserving sight in place is proven, and it is always cheaper, safer, and better than recovering it.

The capability being built toward: When fully built, the aim is a first line of defense that strengthens the eye’s own resilience so reliably that less damage ever reaches the point of needing restoration — reducing how often every later layer is called on. Detailed in Vision Preservation and carried across a lifetime in lifelong resilience. What is real today is early detection and protecting existing defenses; the direction is a self-reinforcing safeguard that keeps sight intact for far more eyes.

AI-based early detection from routine retinal imaging, endogenous neuroprotection (Nrf2 and neurotrophic defenses), and whole-body control of the conditions that damage the eye — the grounded, demonstrated first layer of the system.

The first AI trusted to detect eye disease on its own. Michael Abramoff and his team at the University of Iowa built IDx-DR, which in 2018 became the first AI authorized by the FDA to detect eye disease directly from retinal photographs without a specialist — turning early detection into a scalable first line.

Controlling the body protects the eye. The NIH DCCT Research Group showed in a randomized trial that intensive blood-sugar control cut the risk of diabetic retinopathy by about 76% — proof that upstream, whole-body prevention preserves sight.

The eye’s own antioxidant switch defends its neurons. Elia Duh’s lab at Johns Hopkins University showed the Nrf2 pathway turns on the retina’s own protective genes against the oxidative stress that degenerates it — the endogenous defense the preserve layer keeps strong.

Research & institutions: Michael Abramoff at the University of Iowa, Google DeepMind with Moorfields Eye Hospital and University College London, the NIH DCCT/EDIC Research Group, Elia Duh at Johns Hopkins University, Emily Chew and the AREDS teams at the National Eye Institute, the Wilmer Eye Institute at Johns Hopkins, Mass Eye and Ear and Harvard Medical School, the Glaucoma Research Foundation, Stanford ophthalmology AI research, the National Eye Institute, the Department of Defense Vision Research Program (CDMRP), and the broader preservation and early-detection field.

Demonstrated components (today): The body’s own biology already does real restorative work: AI can map which cells survive and which route can recover them, own-cell therapies already rebuild parts of the eye in people, and the visual brain re-learns to use a recovered signal. Returning function from the eye’s own tissue is clinically demonstrated, not theoretical.

The capability being built toward: When fully built, the aim is to plan the safest, most effective recovery for each eye and bring sight back from the body’s own biology — a dependable bridge from a damaged eye to working sight. Detailed in Vision Restoration. What is real today is own-cell rebuilding of parts of the eye plus AI survival-mapping and cortical re-learning; the direction is integrating these into one routinely reliable restoration path for every recoverable eye.

AI mapping of which cells can recover, own-cell tissue restoration, and the brain’s re-learning of restored signals — partly clinical today, with full restoration of the retina and optic nerve still frontier.

AI reads the eye at specialist level to guide care. DeepMind, with Moorfields Eye Hospital and University College London, built a system that analyzed 3D OCT scans, identified more than 50 retinal conditions, and recommended the correct care on par with world-leading specialists (De Fauw et al., Nature Medicine, 2018).

Sight already restored from a person’s own cells. Graziella Pellegrini and Michele De Luca restored corneal-surface sight with patients’ own stem cells (Holoclar), and Ula Jurkunas’s NEI-funded CALEC trial at Mass Eye and Ear repaired previously “irreversible” corneal damage with a patient’s own cells (Nature Communications, 2025).

The brain re-learns to see. Pawan Sinha at MIT (Project Prakash) showed the visual brain can learn to see even after years of blindness — so a recovered signal becomes usable sight.

Research & institutions: Google DeepMind with Moorfields Eye Hospital and University College London, Graziella Pellegrini and Michele De Luca at the University of Modena and Reggio Emilia, Ula Jurkunas at Mass Eye and Ear and Harvard Medical School, Pawan Sinha at the Massachusetts Institute of Technology, the NEI Audacious Goals Initiative, ARPA-H’s restore-vision program, Robin Ali’s retinal cell-therapy research at University College London, the London Project to Cure Blindness, the National Eye Institute, the Department of Defense Vision Research Program (CDMRP), and the broader vision-restoration field.

Demonstrated components (today): The eye’s structures — the retina’s light-sensing neurons, the optic nerve’s fibers, the cornea’s clear surface, and the natural lens — are made of the body’s own cells, and regrowing damaged tissue from those cells (rather than replacing it with a device) is the engine of this layer. Components across retinal, optic-nerve, corneal, and lens regeneration are at varying stages of real biological proof.

The capability being built toward: When fully built, the aim is to unite those four deep capabilities into one regrowth layer that rebuilds whatever preservation failed to protect and restoration needs as new tissue — all from the eye’s own biology. What is real today is regenerative progress within each individual structure; the direction is a single coordinated regrowth capability spanning every part of the eye, the frontier this layer is driving toward.

Endogenous regeneration across the eye — reawakening the retina’s own repair cells, releasing the optic nerve’s dormant growth program, and regrowing the cornea and lens from the eye’s own cells — clinical for the front of the eye, frontier for the retina and nerve.

The retina’s own repair cells, reawakened. Jin Woo Kim’s team at the Korea Advanced Institute of Science and Technology showed that lifting a natural brake (PROX1) reawakened the retina’s own Müller-glia repair cells and recovered vision in disease-model animals (Nature Communications, 2025); Thomas Reh at the University of Washington had shown the proneural factor Ascl1 drives the same regeneration.

The cornea and lens, regrown from the eye’s own cells. Ula Jurkunas’s CALEC trial rebuilt the corneal surface from a patient’s own stem cells (2025), and Kang Zhang, Yizhi Liu, and Haotian Lin regrew whole functional lenses in infants from their own cells (Nature, 2016).

The optic nerve’s dormant growth program, released. Zhigang He at Boston Children’s Hospital showed that releasing the PTEN and SOCS3 brakes regrows severed optic-nerve fibers in animal models — the reconnection engine, from the nerve’s own biology.

Research & institutions: Jin Woo Kim at KAIST, Thomas Reh at the University of Washington, Ula Jurkunas at Mass Eye and Ear, Kang Zhang, Yizhi Liu, and Haotian Lin at UC San Diego and the Zhongshan Ophthalmic Center, Zhigang He at Boston Children’s Hospital, Graziella Pellegrini and Michele De Luca at the University of Modena, David Gamm at the University of Wisconsin–Madison, the NEI Audacious Goals Initiative, the NEI-supported RReSTORe consortium, the Department of Defense Vision Research Program (CDMRP), and the broader ocular-regeneration field.

Demonstrated components (today): Sight depends on the eye’s own wiring — the optic nerve carrying the signal and the visual brain reading it — and the brain’s native plasticity to reinterpret a restored signal is real and usable today. Work on regrowing the optic nerve’s link and on harnessing cortical plasticity draws directly on the body’s own neural biology.

The capability being built toward: When fully built, the aim is to reconnect the eye to the cortex end to end — uniting optic-nerve regeneration with neurovisual restoration so a repaired eye actually becomes seeing. This closes the loop between a rebuilt eye and vision. What is real today is the brain’s demonstrated capacity to relearn vision and early optic-nerve link work; full nerve-to-cortex reconnection is the frontier this layer is built toward.

Regrowth of optic-nerve axons to their correct brain targets, and the cortex’s own plasticity re-learning to interpret restored input — the link that turns a repaired eye into usable sight, largely frontier.

Optic-nerve fibers regrown toward the brain. Zhigang He and Larry Benowitz at Boston Children’s Hospital and Harvard Medical School showed that combining growth signals regrows ganglion-cell axons the length of the optic nerve, with some reaching their brain targets and partial vision returning (de Lima et al., PNAS, 2012).

The visual brain can recover and re-learn. Krystel Huxlin at the University of Rochester showed that training recovers real vision in cortically blind fields, and Pawan Sinha (Project Prakash) showed the brain learns to see after long blindness — the cortex’s own plasticity closing the loop.

Guiding the signal back correctly. Carol Mason at Columbia University mapped how visual-pathway axons navigate to their correct side of the brain — the wiring rules a reconnected nerve must follow to carry an organized image.

Research & institutions: Zhigang He and Larry Benowitz at Boston Children’s Hospital and Harvard Medical School, Krystel Huxlin at the University of Rochester, Pawan Sinha at the Massachusetts Institute of Technology, Carol Mason at Columbia University, the NIH BRAIN Initiative, the NEI Audacious Goals Initiative, Moorfields Eye Hospital and University College London, the Department of Defense Vision Research Program (CDMRP), Mass Eye and Ear and Harvard Medical School, Andrew Huberman at Stanford University, and the broader visual-pathway reconnection field.

Demonstrated components (today): The brain’s own perceptual learning is a real, trainable biology, and supporting the eye’s natural optics is grounded in the body’s existing structures. Sharpening, speeding, and strengthening healthy and recovered sight from this own trainable biology — with no new harm — is demonstrated as meaningful improvement, presented honestly rather than as unlimited enhancement.

The capability being built toward: When fully built, the aim is to push every secured eye past merely adequate toward the best vision its biology supports — pairing perceptual learning with natural-optics support so good sight becomes excellent. Detailed in Vision Optimization. What is real today is genuine, bounded gains from trainable biology; the direction is reliably optimizing each person’s vision to its biological best, honestly framed as improvement and not limitless enhancement.

Perceptual learning, the eye’s own optics, and AI-personalized training — demonstrated, behavioral routes that strengthen healthy and recovered vision within the system’s limits.

Training sharpens even already-healthy eyes. Aaron Seitz at the University of California, Riverside put a college baseball team through perceptual-learning training and improved their vision beyond normal, with measurable on-field gains (Deveau, Ozer & Seitz, Current Biology, 2014).

The adult visual brain stays trainable. Avi Karni and Dov Sagi at the Weizmann Institute of Science showed visual practice produces lasting improvements tied to adult visual-cortex change (Karni & Sagi, Nature, 1991), the basis for optimizing sight.

AI personalizes the training. Zhong-Lin Lu at New York University built the quick Contrast Sensitivity Function, measuring a person’s full visual profile in minutes so training can be matched to the individual.

Research & institutions: Aaron Seitz at the University of California, Riverside and Northeastern University, Avi Karni and Dov Sagi at the Weizmann Institute of Science, Dennis Levi at the University of California, Berkeley, Barbara Dosher at the University of California, Irvine and Zhong-Lin Lu at New York University, David Williams at the University of Rochester, the National Eye Institute, the Department of Defense Vision Research Program (CDMRP), the University of Rochester Center for Visual Science, and the broader visual-performance field.

Demonstrated components (today): The eye has its own renewal and defense systems, and supporting them, predicting decline early, protecting the whole pathway, and recovering loss as a backstop all draw on the body’s own biology. Elements of this lifelong upkeep — early prediction and protective support — are grounded in real capability today, so sight need not be surrendered piece by piece with age.

The capability being built toward: When fully built, the aim is to keep the whole system working across a lifetime as one lifelong axis — renewal, prediction, pathway protection, and backstop recovery sustaining sight rather than letting it erode. Detailed in Lifelong Visual Resilience. What is real today is early-decline prediction and defense support; the direction is a complete, self-renewing capability that holds the result for a lifetime — still the frontier.

Lifelong ocular self-renewal and defense, AI prediction of decline, whole-pathway protection, and restoration as a backstop — the integration of every layer across decades, grounded today with restoration still advancing.

The eye renews itself for life. Richard Young’s discovery of continuous photoreceptor renewal and Nick Di Girolamo’s live imaging of the cornea endlessly resurfacing itself prove the eye runs lifelong self-renewal — the upkeep resilience supports.

The retina as a lifelong gauge of whole-body health. Pearse Keane’s group at Moorfields and University College London built RETFound and pioneered “oculomics,” reading the retina to predict eye and systemic disease over time (Nature, 2023) — turning a scan into a years-ahead view of where sight is heading.

Prevention sustains sight across the lifespan. The NIH DCCT Research Group (76% less retinopathy with whole-body control) and the retina’s own dopamine growth-control biology (Wallman, Stone, and Pardue) showed sight can be protected from the start of life onward.

Research & institutions: Pearse Keane at Moorfields Eye Hospital and University College London, the foundational renewal work of Richard Young and Dean Bok, Nick Di Girolamo at the University of New South Wales, the NIH DCCT/EDIC Research Group, Richard Stone and Machelle Pardue’s eye-growth-control research, Emily Chew at the National Eye Institute, the Wilmer Eye Institute at Johns Hopkins, the Foundation Fighting Blindness, the Department of Defense Vision Research Program (CDMRP), Mass Eye and Ear and Harvard Medical School, and the broader lifelong-eye-health and oculomics field.

Demonstrated components (today): Every layer of this system runs on the body’s own biology, and several are clinically real now — preservation and own-cell restoration in particular — while regeneration, reconnection, optimization, and lifelong sustaining advance at their own stages. The individual capabilities being coordinated are concrete, not hypothetical.

The capability being built toward: When fully built, the aim is one coordinated pipeline matched to each person’s biology: a regenerated retina routed to a reconnected nerve and a responsive brain, preservation reducing the need for restoration, resilience keeping the result, and optimization bringing it to its best — with AI personalizing the plan and supporting clinicians, never replacing them. Run as one system through the body’s own biology, this is where preventable and reversible blindness ends. What is real today is the proven layers; full end-to-end integration is the frontier — the unifying aim of the whole Eyes & Vision capability.

Coordination of preservation, restoration, regeneration, neurovisual reconnection, optimization, and resilience into one personalized pipeline — demonstrated where the layers are grounded, frontier where regeneration and reconnection still advance.

A coordinated national goal, not a slogan. The National Eye Institute’s Audacious Goals Initiative funds the regeneration of the visual system’s neurons and their connections as one program — the explicit, coordinated effort to restore vision across the whole pathway, exactly the integration this capability names.

The proof the layers already connect. Across the system — CALEC restoring the cornea from a patient’s own cells, infant lenses regrown, the retina’s repair cells reawakened, the optic nerve’s growth program released, and the visual brain re-learning to see — each layer has real, named proof, and together they form one body’s-own-biology pipeline.

The honest bound. Preservation and optimization are grounded today; restoration and regeneration are advancing and largely frontier. The end of preventable and reversible blindness is the outcome these capabilities are built to reach, presented honestly — a real, coordinated direction, not a finished cure.

Research & institutions: the National Eye Institute and its Audacious Goals Initiative, ARPA-H’s restore-vision program, the NIH BRAIN Initiative, the Department of Defense Vision Research Program (CDMRP), the NEI-supported RReSTORe consortium, Mass Eye and Ear and Harvard Medical School, Johns Hopkins, the University of Wisconsin, the University of Washington, the academic vision centers spanning every vision capability, and the broader integrated Eyes & Vision field.